Acousia Therapeutics
About
Acousia Therapeutics is a privately held biotech company.
- Tübingen,Baden-Wurttemberg,Germany
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- €2.50M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2012
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Legal Name
- Acousia Therapeutics GmbH
Acousia Therapeutics GmbH is a privately held biotech company based in Tübingen, Germany. Acousia has experience and expertise in identifying and developing small molecule drug candidates for the treatment of hearing loss.Sensory hair cells are the key cells for hearing in the inner ear. Acousia`s approach will help to replace lost hair cells by cellular regeneration originating from supporting cells.ASpherecousia is developing drugs for local application, which will restore hearing in patients who have lost their hearing ability induced by various reasons, e.g. noise trauma, treatment with ototoxic drugs or sudden deafness. In addition, these therapies will have the potential to treat the age-related decrease in hearing capacity.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 14, 2018 | Series B | €10M | 5 |
Creathor Ventures
|
— | Detail |
| Dec 14, 2016 | Series A | €2.50M | 3 |
Boehringer Ingelheim Venture Fund
|
— | Detail |
| Jan 1, 2012 | Seed | — | — | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Creathor Ventures
|
Yes | Series B |
|
Boehringer Ingelheim Venture Fund
|
— | Series B |
|
|
— | Series B |
KfW
|
— | Series B |
LBBW VC
|
— | Series B |
|
|
— | Series A |
Employee Profiles
